Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gebremeskelon Apr 07, 2021 9:54am
139 Views
Post# 32948434

RE:RE:RE:Aga cancelled

RE:RE:RE:Aga cancelledAristotle is considered experimental technology by insurance companies. The Aristotle rollout was tied to a small cancer treatment company which is not mainstream. I don't think you need to look any farther than that.
Liked2Think wrote: I got the same too.  She is likely just copying and pasting that email into tons and tons of emails.

meanwhile I show us at 88 cents and the market isnt open yet.

will be a miracle to hold the 80 cent mark today.

I dont think this is some squeeze play that a couple others of insinuated.  if anything the shorters love what happened.  They drove this down and now I bet they are buying back in.

Once again the shorters are the ones to make money on this company and long term investors are left to twist in the wind.


<< Previous
Bullboard Posts
Next >>